Final SVR24 Data From the Phase 3 C-Edge Treatment-Naïve Study of Elbasvir (EBR)/Grazoprevir (GZR) in Patients with Chronic HCV Genotype 1, 4 or 6 InfectionStefan Zeuzem, Eléonora De Martin, Ziv Ben Ari et al.|Journal of Hepatology|2016Cited by 1
Pervasive Adaptation of Hepatitis C Virus to Interferon Lambda Polymorphism Across Multiple GenotypesNimisha Chaturvedi, Jacques Fellay, Evguenia S. Svarovskaia et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 0